MARISSA SHISLER: Open Payments
NPI 1760999692 · PUEBLO, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$797 in 49 payments from 15 companies in 2025. Trend: 2023 $543 · 2024 $387 · 2025 $797
Food & beverage: $797
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 17 | $190 |
| Novo Nordisk Inc | 10 | $176 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $75 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| ABBVIE INC. | 2 | $41 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| Astellas Pharma US Inc | 2 | $40 |
| PFIZER INC. | 2 | $36 |
| Kowa Pharmaceuticals America, Inc. | 2 | $31 |
| SANOFI PASTEUR INC. | 1 | $30 |
Products named: OTEZLA, Wegovy, Ozempic, CAPLYTA, KRYSTEXXA, VRAYLAR, Veozah, ZORYVE.
Industry payments across CO — which companies pay providers there.
